McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

CancerIQ Raises $14M Series B Funding to Improve Access to Innovations in Cancer Early Detection and Prevention

by McKesson Ventures | Mar 3, 2022 | Press Releases

CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, has closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. Other investors participating in the...
Page 2 of 2«12

Recent Posts

  • CoverMyMeds Announces Acquisition of Companies RxLightning and FastAuth
  • Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
  • Atropos Health Expands Oncology MultiModal Network in the Atropos Evidence Network with Addition of Ontada
  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration

HarmonyCares Announces 2023 Results for its High Needs REACH ACO

Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow